Private Companies
Since its inception, Sanderling has supported more than 90 new start-up biomedical companies, and has consistently earned high rates of return, building a superior track record of success. Selected examples of private companies are listed below:
 |
Altor Bioscience is a biopharmaceutical company developing a new class of therapeutic products for the treatment of cancer, viral infections and autoimmune diseases. |
Altor BioScience Corp. 2810 North Commerce Parkway Miramar, FL 33025-3958 Phone: (954) 443-8601 Fax: (954) 443-8610 www.altorbioscience.com |
 |
Artielle is focused on treatments for autoimmune disorders using a new proprietary class of molecules known as Recombinant T cell receptor Ligands (RTLs). Artielle has developed a lead compound for the treatment of multiple sclerosis, called RTL1000, which has received Orphan Drug status from the U.S. FDA. |
Artielle Immunotherapeutics, Inc. 9020 SW Washington Square Road, Suite 450 Tigard, OR 97223 Phone: (503) 626-1144 Fax: (503) 627-0984 www.artielle.com |
 |
Asteres develops and manufactures merchandise storage and self-checkout machines for use in retail pharmacies. The Asteres ScriptCenter® has the potential to bring an entirely new level of convenience and customer-service to the retail pharmacy industry. |
Asteres Inc. 4110 Sorrento Valley Blvd. San Diego, CA 92121 Phone: (858) 777-8600 Fax: (858) 866-0669 www.asteres.com |
 |
Axikin Pharmaceuticals, is focused on the development of small molecule therapeutics for novel GPCR and kinase targets central to the inflammatory process, the antagonism of which is predicted to ameliorate allergic and respiratory disorders such as rhinitis and asthma. | Axikin Pharmaceuticals 10835 Road To The Cure Suite 250 San Diego, CA 92121 Phone: (858) 458-1890 Fax: (858) 458-1896 www.axikin.com |
 |
CalciMedica is dedicated to the discovery and development of novel small molecule drugs for the treatment of autoimmune and inflammatory diseases as well as organ transplant rejection. A significant focus of the company’s drug discovery strategy is based on the specific inhibition of calcium release-activated calcium (CRAC) channels. |
CalciMedica 505 Coast Blvd. S, Suite 209 La Jolla, CA 92037 Phone: (858) 952-5501 Fax: (858) 952-5490 www.calcimedica.com |
 |
CoMentis (formerly Athenagen) is developing small-molecule drugs designed to either inhibit or enhance angiogenesis. The company’s technology is based on a new angiogenesis pathway located on endothelial cells discovered at Stanford University in the late 1990s. |
CoMentis, Inc. 280 Utah Avenue, Suite 275 South San Francisco, CA 94080 Phone: (650) 869-7600 Fax: (650) 869-7626 www.comentis.com |
 |
Cylene is developing small molecule drug candidates designed to selectively target quadruplex-forming nucleic acid structures relative to other classes of quadruplexes and other forms of DNA or RNA. The company is also leveraging its internal discovery platform to generate other novel anti-cancer agents. |
Cylene Pharmaceuticals, Inc. 5820 Nancy Ridge Drive, Suite 200 San Diego, CA 92121 Phone: (858) 875-5100 Fax: (858) 875-5101 www.cylenepharma.com |
 |
DynaTherm Medical develops and commercializes products for temperature management in surgical, emergency, field and industrial settings. The company's patent protected technology uses non-invasive negative pressure to access the body's natural thermoregulatory system, the AVA's (arteriovenous anastomoses). |
Dynatherm Medical Inc. 42840 Christy Street, Suite 108 Fremont, CA 94538 Phone: (510) 249-1300 Fax: (510) 440-9909 www.dynathermmedical.com |
|
InfraReDx is developing photomedical techniques and catheter-based systems that will enable the interventional cardiologist to not only identify, but also treat vulnerable plaques in the coronary artery. |
InfraReDx 34 Third Avenue Burlington, MA 01803 Phone: (781) 221-0053 Fax: (781) 272-5290 www.infraredx.com |
 |
LineaGen, Inc. is a content-based biomarker discovery company focused on the commercialization of novel, patentable diagnostic tests that will lead to more personalized healthcare regimens for human health and disease conditions. LineaGen’s goal is to develop a diversified portfolio of novel biomarkers for the development of new diagnostic tests. |
LineaGen, Inc. 423 Wakara Way, Suite 200 Salt Lake City, UT 84108 Phone: (801)931-6200 Fax: (801)931-6176 www.lineagen.com |
 |
Naviscan, Inc. designs and develops compact, high-resolution, positron emission tomography (PET) scanners that are intended to guide challenging radiological and surgical procedures. |
Naviscan, Inc. 4401 Eastgate Mall San Diego, CA 92121 Phone: (858) 587-3641 Fax: (858) 587-2596 www.naviscan.com |
|
NovoStent is developing a unique helical stent and integrated delivery system is designed to provide easy deployment and accurate, zero-foreshortening delivery. |
NovoStent Corporation 1400 Terra Bella Avenue, Suite E Mountain View, CA 94043 Phone: (650) 404-0300 Fax: (650) 404-0301 www.novostent.com |
|
Pulsar Vascular is an early stage medical device company specializing in the design and development of innovative medical devices for the endovascular treatment of neurovascular disorders. |
Pulsar Vascular 4030 Moorpark Avenue, Suite 110 San Jose, CA 95117 Phone: (408) 260-9264 Fax: (408) 260-9264 www.pulsarvascular.com |
 |
Sotera Wireless addresses the lack of an accurate, cost-effective way to monitor and diagnose high blood pressure. The company has developed a cuffless, wrist-worn sensor that continuously measures a patient's beat-to-beat blood pressure, heart rate, and pulse oximetry over a short (e.g., 24-hour) time period. |
Sotera Wireless 6540 Lusk Blvd., Suite C200 San Diego, CA 92121 Phone: (858) 427-4620 Fax: (858) 427-4639 www.soterawireless.com |
 |
Tenex Greenhouse Ventures is a Center for Life Science Innovation, which is a joint venture between the Tenex Angel Investment Group and Sanderling Ventures. | Tenex Greenhouse Ventures 839 Mitten Road, Suite 200 Burlingame, CA 94010 Phone: (650) 697-7120 Fax: (650) 697-7119 www.10xgreenhouse.com |
 |
TheraVida is developing a novel combination drug product platform, with the potenial to significantly improve existing therapies for a variety of diseases. The company is currently focusing its efforts on the treatment of urological disorders. |
TheraVida, Inc. 800 W. El Camino Real, Suite 180 Mountain View, CA 94040 Phone: (650) 903-2225 Fax: (650) 962-1188 www.theravida.com |
|
Theregen Corporation is a regenerative medicine company that develops cell-based therapies for patients with cardiovascular and vascular disease and is developing its lead product, Anginera™, for these applications. |
Theregen Corporation 225 Bush St., 16th Fl. San Francisco, CA 94014 Phone: (415) 439-8320 Fax: (415) 439-8304 www.theregen.com |
 |
Tomophase Corporation was founded with the mission of developing innovative solutions for minimally invasive diagnostic (MID) imaging. The company is using light to guide new ways of diagnosing diseases and has conceived major innovative ideas for an optical MID imaging system |
Tomophase Corporation 1 North Avenue Burlington, MA 01803 Phone: (781) 229-5700 Fax: (781) 229-5737 www.tomophase.com |
 |
Torax Medical, Inc. is a medical device company located in Minneapolis, MN. Torax is focused on developing technology for minimally invasive treatment of digestive disorders. |
Torax Medical, Inc. 4188 Lexington Avenue North Shoreview, MN 55126 Phone: (651) 361-8900 Fax: (651) 361-8910 www.toraxmedical.com |
|
ViaCyte is developing cell therapy products using its proprietary cell encapsulation technology. ViaCyte’s ultimate goal is to develop a renewable source of specialized cells that can be used to treat chronic cellular diseases. |
ViaCyte, Inc. 3550 General Atomic Court Building 2, Suite 503 San Diego, CA 92121-1122 Phone: (858) 455-3708 Fax: (858) 455-3962 www.viacyte.com |